![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
K Inui, T Okano, H Maegawa, M Kato, M Takano and R Hori
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Japan.
We demonstrated previously that aminocephalosporins, such as cephradine, possessing a alpha-amino group and a carboxyl group, are transported via H+/dipeptide carrier system in the intestinal brush- border membranes. The present study examined the transport characteristics of cefixime, a new p.o. cephalosporin with two carboxyl groups, by the rabbit intestinal brush-border membrane vesicles in comparison with those of cephradine. With an intravesicular pH of 7.5, apparent optimum extravesicular pH was 6.0 for cephradine uptake and more acidic (pH 4.5-5.0) for cefixime uptake. An inward H+ gradient [( pH]i = 7.5, [pH]o = 5.0) induced overshoot uptake of cefixime, and this uptake was reduced in the presence of carbonyl cyanide p- trifluoromethoxyphenylhydrazone, a protonophore. Cefixime uptake at pH 5.0 was trans-stimulated (countertransport effect) and cis-inhibited by dipeptides and aminocephalosporins but not at pH 7.5. Cephradine uptake at pH 7.5 was stimulated by the countertransport effect of dipeptide but not by cefixime. Cefixime and cephradine uptake at pH 5.0 was greatly inhibited by 4,4'-diisothiocyano-2,2'-disulfonic stilbene. These findings indicate that cefixime is transported by an inward H+ gradient via dipeptide carrier only in an acidic pH region, whereas cephradine is transported via dipeptide carrier in both neutral and acidic pH regions, suggesting the existence of multiple transport systems for dipeptides; a neutral pH preferring system (Type I) and an acidic pH preferring system (Type II).
This article has been cited by other articles:
|
|
 |
|
  C. S. Lepsy, R. J. Guttendorf, A. R. Kugler, and D. E. Smith Effects of Organic Anion, Organic Cation, and Dipeptide Transport Inhibitors on Cefdinir in the Isolated Perfused Rat Kidney Antimicrob. Agents Chemother., February 1, 2003; 47(2): 689 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Groneberg, F. Doring, S. Theis, M. Nickolaus, A. Fischer, and H. Daniel Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1172 - E1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Groneberg, F. Doring, P. R. Eynott, A. Fischer, and H. Daniel Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1 Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G697 - G704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J F Poschet, S M Hammond, and P D Fairclough Characterisation of penicillin G uptake in human small intestinal brush border membrane vesicles Gut, May 1, 1999; 44(5): 620 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Iseki, M. Sugawara, K. Sato, I. Naasani, T. Hayakawa, M. Kobayashi, and K. Miyazaki Multiplicity of the H+-Dependent Transport Mechanism of Dipeptide and Anionic beta -Lactam Antibiotic Ceftibuten in Rat Intestinal Brush-Border Membrane J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 66 - 71. [Abstract] [Full Text]
|
|
|
|
|
|
T. Terada, H. Saito, M. Mukai, and K.-I. Inui J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1415 - 1421. [Abstract]
|
|
|
|
|
|
L. Harcouët, D. Lebrec, C. Rozé, C. Carbon, and R. Farinotti Increased Intestinal Absorption of Cefixime by Nifedipine in the Rat Intestinal Perfusion Model: Evidence for a Neural Regulation J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 738 - 745. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
